• RNA Pol II Inhibition Triggers Apoptosis via Loss of Pol IIA

  2026-04-20

  Harper et al. (2025) demonstrate that cell death from RNA Pol II inhibition results from the loss of hypophosphorylated RNA Pol IIA, not from passive mRNA decay as previously thought. This mechanistic insight reshapes our understanding of apoptosis in response to transcriptional blockade and suggests new directions for cancer therapy research.

• Tropisetron Hydrochloride: Precision Tools for 5-HT3 Pathway

  2026-04-20

  Explore the advanced utility of Tropisetron Hydrochloride as a selective 5-HT3 receptor antagonist in neuroscience receptor modulation and transporter interaction studies. This article offers a uniquely practical, assay-focused perspective on optimizing serotonin receptor signaling research.

• Scenario-Driven Solutions with Dihydroethidium (DHE, SKU C38

  2026-04-19

  This article delivers practical, evidence-based guidance for biomedical researchers using Dihydroethidium (DHE, SKU C3807) as a robust probe for superoxide detection and oxidative stress assays. Drawing on real laboratory scenarios, we illustrate how DHE enables sensitive, reproducible intracellular reactive oxygen species measurement and data interpretation in apoptosis, cardiovascular, and cancer research.

• A Unified Protocol for mRNA LNP Formulation and Evaluation

  2026-04-18

  Ma et al. present a comprehensive, stepwise protocol for the formulation, characterization, and evaluation of mRNA lipid nanoparticles (LNPs), lowering technical barriers for new entrants to the field. Their workflow integrates microfluidic mixing, robust physicochemical characterization, and both in vitro and in vivo testing, streamlining the experimental process for diverse mRNA delivery applications.

• HyperScribe™ T7 Kit for High-Yield RNA in Gene Editing Workf

  2026-04-17

  Explore how the HyperScribe T7 High Yield RNA Synthesis Kit streamlines high-yield in vitro RNA production for CRISPR gene editing. This article reveals workflow-critical insights and practical advances not covered elsewhere.

• S63845 MCL1 Inhibitor: Precision Tools for Apoptosis Researc

  2026-04-16

  S63845 is redefining apoptosis research as a highly selective, nanomolar-potent MCL1 inhibitor, enabling direct activation of the mitochondrial apoptotic pathway in hematological cancer models. This article details robust protocols, advanced use-cases, and troubleshooting strategies for leveraging S63845 in high-impact cancer research workflows.

• Machine Learning-Guided Discovery of Senolytics: Study Insig

  2026-04-15

  This article analyzes the 2023 Nature Communications study that applied machine learning to identify novel senolytic compounds capable of selectively eliminating senescent cells. The findings demonstrate that AI-driven approaches can efficiently accelerate senolytic discovery, with implications for cancer, aging, and translational research workflows.

• Macrophage-EV miR-660 Drives Breast Cancer Metastasis via KL

  2026-04-14

  This study uncovers how tumor-associated macrophages (TAMs) promote breast cancer progression by transferring extracellular vesicle (EV)-enclosed microRNA-660 to tumor cells, suppressing KLHL21 and activating the NF-κB pathway. These findings identify a novel mechanism of metastatic regulation and suggest new targets for therapeutic intervention in aggressive breast cancer.

• DMH1: ALK2 Inhibitor Workflow Advances for Organoid & NSCLC

  2026-04-13

  DMH1 stands out as a selective ALK2 inhibitor that empowers both organoid engineering and non-small cell lung cancer research with precise BMP pathway control. This guide details experimental workflows, troubleshooting insights, and protocol optimizations to maximize the impact of DMH1 in cutting-edge research applications.

• Paclitaxel (Taxol) SKU A4393: Reliable Solutions for Cancer

  2026-04-12

  This article delivers scenario-driven, evidence-based guidance for using Paclitaxel (Taxol) (SKU A4393) in cell viability, cytotoxicity, and proliferation assays. By addressing real laboratory challenges, it demonstrates how Paclitaxel (Taxol) ensures experimental reproducibility and data integrity for cancer research applications.

• FerroOrange: Next-Gen Fe²⁺ Fluorescent Probe for Neuronal Fe

  2026-04-12

  Explore how FerroOrange, an advanced Fe²⁺ fluorescent probe, uniquely empowers live cell iron detection and neurodegeneration research. This in-depth article dives into assay optimization, mechanistic insights, and practical advances for intracellular iron detection.

• THZ1: Covalent CDK7 Inhibitor Workflows for Cancer Biology

  2026-04-11

  THZ1 is a next-generation covalent CDK7 inhibitor uniquely suited for dissecting transcriptional dependencies and overcoming resistance in cancer research. This guide delivers actionable protocols, troubleshooting insights, and the latest comparative innovations to maximize success in T-ALL and broader oncology workflows.

• Optimizing PCR and DNA Synthesis with 10 mM dNTP Mixture

  2026-04-11

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture unlocks reproducible, high-sensitivity PCR and DNA synthesis workflows, offering precise nucleotide delivery for advanced molecular biology and nanoparticle-based assays. Explore protocol enhancements, troubleshooting strategies, and evidence-driven best practices for maximizing assay reliability with this molecular biology reagent.

• Optimizing Macrophage Assays: Recombinant Mouse Macrophag...

  2026-04-10

  This article addresses persistent challenges in macrophage viability, proliferation, and polarization assays, providing actionable guidance for bench scientists. Leveraging SKU PM2021, Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag, we dissect experimental design, data interpretation, and product selection for reproducible and translational workflows in immunology, cancer, and fibrosis research.

• Fingolimod (FTY720): S1P Receptor Modulation in Advanced ...

  2026-04-09

  Explore the unique role of Fingolimod (FTY720) as a sphingosine-1-phosphate receptor modulator in next-generation in vivo immune cell engineering and neuroprotection. This in-depth analysis uncovers its mechanistic distinctiveness and translational applications beyond multiple sclerosis therapy.

406 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page